Miltefosine

Product description

Miltefosine is a pharmaceutical substance for the treatment of parasite-induced leishmaniasis. It is used in human and veterinary medicines and is taken orally in the form of tablets.

Comprehensive documentation for drug registration of Miltefosine can be provided by Biesterfeld as referred.

CAS-No. Regulatory Monograph
58066-85-6 ASMF IH

Tradename(s)

Miltefosine (Antileishmanial)

Country availability

Available worldwide

contact

Contact person

Jan Knudsen

Jan Knudsen

Sales

phoneShow phone number
email Send E-Mail